MetLife, Inc. (NYSE:MET) is among the
8 Low-cost Giant Cap Shares to Purchase Now. On April 9, 2026, UBS raised the value goal on MetLife, Inc. (NYSE:MET) to $102 from $98 and maintained a Purchase score. UBS mentioned the replace displays modifications throughout the North American life insurance coverage group forward of Q1 earnings, noting continued concentrate on incapacity margins with “comparatively restricted wiggle-room” given cyclicality and financial uncertainty, whereas rolling its valuation to 2027 estimates.
On the identical day, MetLife Funding Administration mentioned it originated roughly $26B in non-public fastened revenue transactions in 2025, bringing complete belongings below administration on its platform to $144.7B as of December 31, 2025. The platform contains non-public company and infrastructure debt, asset-based finance, residential loans, and sustainable finance, with originations together with $8.9B in residential credit score, $6.8B in company debt, $5.7B in infrastructure debt, and $4.5B in asset-based finance.
On April 8, 2026, Barclays lowered its value goal on MetLife to $89 from $92 and maintained an Obese score. Barclays mentioned premium progress and dealer natural progress are anticipated to stay sluggish, however famous that margins and capital deployment ought to proceed to help ebook worth progress.
MetLife, Inc. (NYSE:MET) offers insurance coverage, asset administration, and monetary companies globally.
Whereas we acknowledge the potential of MET as an funding, we consider sure AI shares provide larger upside potential and carry much less draw back threat. Should you’re searching for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the greatest short-term AI inventory.
READ NEXT: 33 Shares That Ought to Double in 3 Years and Cathie Wooden 2026 Portfolio: 10 Finest Shares to Purchase.
Disclosure: None. Comply with Insider Monkey on Google Information.
